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This write up is an attempt to collate information on 
biodiversity and biotechnology interactions and inter 
relationships in general and examine the status of benefit 
sharing mechanisms in place when marine biodiversity is used 
in development of products and services. Additionally, the 
less known `biomimicry’ which draws inspiration from nature 
for development of products and services is also introduced 
with examples.
United Nations Conference on Environment Development 
(UNCED) also known as the Rio Summit in 1992 made 
biodiversity a very common word. This was followed by 
United Nations Conference on Sustainable Development in 
2012 again at Rio. Biodiversity depends on the stability of the 
biosphere which in turn stabilizes climate, water, soil, air and 
overall health of the biosphere.
Biodiversity is the resource and strength of developing countries. 
Evidently, developing countries are located in the tropics and 
sub-tropics which are richer in biodiversity when compared with 
temperate countries. Conservation and sustainable use of the 
country’s biodiversity is central to all developmental planning 
in a country like ours because our mainstay is agriculture and 
animal husbandry is subsidiary to it. 
Aquatic resources mainly from the marine realm also exhibits 
such diversity that our country has five declared marine 
biosphere reserves (Gulf of Mannar, Sundarbans, Great 
Nicobar, North Andaman and Little Rann of Kuchchh) and 
another five have been listed as potential ones (Malvan, Gulf 
of Kahmbatt, Chilka, Lakshwadeep, Bhitar Kanika).
The real value of biodiversity is in the information that is 
encoded in genes and molecules. But biodiversity is attached 
as a frill to the environment and forest agencies that have 
no exposure in product development from biodiversity. 
As mentioned, biodiversity being one of the assets of the 
developing countries, to extract anything from the biota 
a value has to be fixed. An earliest extensively discussed 
example in this regard is the agreement between Merck and 
INbio of Costa Rica.
At this juncture Koshoos model (1994) of biodiversity and 
biotechnology interrelationship is noteworthy. The relationship 
between biodiversity and biotechnology conceptualized by 
him in 1994 is relevant even after 21 years.
The countries of the world are divided into four as given in 
the Table below
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Flow of biodiversity is from south to north and flow of 
biotechnology is from north to south. It is evident that 
biodiversity flow is not equal to biotechnology flow because 
biotechnological developments are capital intensive which are 
faster in developed countries when compared to developing 
countries. 
Countries capable of entering the fourth group are India and 
China and countries in the northern hemisphere can never 
make it to this group because of lack of biodiversity. They may 
have ex situ conservation methods which cannot compensate 
the natural selection process taking place over a period of 
time in countries rich in biodiversity. Thus, Koshoo (1994) 
describes the `biobanks’ in developing nations as ‘green 
morgues’ because germplasm is only `preserved’ there 
instead of ‘conservation’
 At that time itself, Koshoo (1994) said that biodiversity being 
Biodiversity poor, biotechnology 
poor 
Middle east Asian countries like 
Saudi Arabia
Biodiversity poor biotechnology rich Developed countries like USA, 
Japan, France, Germany and UK
Biodiversity rich, biotechnology poor South America, Central Asia and 
Africa
Biodiversity rich, biotechnology rich None
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Fig. Koshoo’s model of biodiversity and biotechnology inter-
relationships
one of the assets of the developing countries, gene and drug 
rush should not take place in a policy vacuum. Gene rich and 
technology poor countries should avoid gene imperialism.
It is estimated that 5-30 million species exist and most of the 
biologists regard 10 million as a conservative estimate. Only 
1.4 million of these species has been named by taxonomists. 
Tropical forests of Central and South America and South East 
Asia, contain 50 – 90 percent of all species.
Unrealized returns from natural resources lead to market 
reforms in valuing biodiversity and sustaining them. Till then 
no economic gain or loss was recorded in a basic accounting 
network when biological resources were used. The natural 
resources were considered free.
The first step towards natural resource control was taken at a 
summit in Managua in Nicaragua in 1992 where the presidents 
of Belize, Costa Rica, El Salvador, Guatemala, Honduras, 
Nicaragua and Panama signed a non-binding resolution 
that encouraged the passage of laws to regulate and restrict 
extraction of natural resources from their countries. The goal 
of the resolution was to prevent foreigners from invading their 
nation’s wild lands and extracting valuable natural resources 
without compensating the host nation.
The Madagascar periwinkle from which the valuable anticancer 
drugs vincristine and vinblastine was the case in point. Over the past 
20 years, World Resources Institute of Washington estimated that 
Costa Rica lost of 4 billion dollars as unrealized returns on natural 
resources.
Thus, harvesting of natural resources unsustainably continued 
unabated till Convention on Biological Diversity (CBD) opened 
for signature in Rio in 1992 and entered in force from 1993. 
After that, as biotechnological tools and techniques lead to 
the development of living modified organisms (LMO) and 
international treaty governing movement of such organisms 
was governed by an international treaty called the Cartagena 
Protocol on biosafety in 2003.
This was followed by Nagoya Protocol adopted in 2010 which said 
that access to genetic resources should be fair and equitable with 
sharing of benefits arising out of their utilization. Biotechnology 
is knowledge intensive and with good infrastructure can lead to 
value addition to the products from biodiversity.
Contract Parties Type and term Scope Benefits to the indigenous 
communities
InBio-Merck INBio-National Biodiversity 
Institute of Costa Rica and Merck 
& Co. Ltd.
Renewable non-exclusive 
2 year
Evaluation of limited of plant, 
insect and microbial samples 
from 11 conservation areas
1 Million USD Equipment for 
processing of samples Scientific 
training
Peruvian ICGB, Bristol, Monsanto, Glaxo, 
Wellcome
Renewable 5 years Collection of Peruvian 
medicinal plants
Lumpsum payment
Suriname Maroon 
tribes
ICGB, Virginia Polytechnic 
Institute and Sate university; 
Conservation International; 
Bedrijf Geneesmiddelen 
Voorzeining Suriname; Missouri 
Botanical Gardens and Bristol-
Myers Squibb Pharmaceutical 
Research institute
Renewable 5 years Collection of botanical and 
ethnobotanical samples, 
inventory, extraction of 
compounds, screening of 
bioactivity and drug 
development
Technical capacity building to 
prepare the plant extracts. 
Laboratory equipment and the 
training to use the equipments.
Kerala India TBGRI and Arya Vaidya 
Pharmacy
11 years Plants with the help of Kani 
community
Lumpsum Royalty Training in local 
sample preparation and screening 
Protection of biodiversity
ICBG International Cooperative Biodiversity Group
TBGRI Tropical Botanical Garden and Research Institute is now known as Jawaharlal Nehru Tropical Botanical Garden and 
Research Institute (JNTBGRI)
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S. No. Legal instrument/organization Key features
1 Convention on Biological diversity (CBD) Govern the different aspects of marine scientific research Share the benefits arising from the 
utilization of genetic resources in a fair and equitable way
2 Bonn guidelines and Nagoya Protocol Access to genetic resources Specialized access and benefit sharing regimes consistent with the 
objectives of CBD Meet the ethical concerns, competing requirements between feed of scientific 
research Exploitation of a resource and benefit to the source owner and society at large Use of 
traditional knowledge associated with genetic resources within the scope
3 United Nations Convention on the Law of the Seas 
(UNCLOS)
Defines the rights and responsibilities of nations with respect to their use of world’s oceans 
Establishing guidelines for businesses, the environment, and the management of marine 
natural resources
4 International Sea Bed Authority Provides rules and provisions to regulate prospecting, exploration of marine minerals in the 
international seabed area
5 Global Ocean Commission Recommend policies for governance in the high seas Recommend amendment of UNCLOS 
Enable governance at the regional level
6 European Science Foundation Envisages to develop principles on the simplification and harmonization of regulations on 
access and fair and equitable benefit sharing arising from the exploitation of marine genetic 
resources
7 Valencia Declaration Governance regime for regulation of activities in the marine areas
8 Europe Micro B3 (3 Bs are Microbial biodiversity, 
bioinformatics and biotechnology)
Development standards for sampling marine microorganisms
The conference of parties in October 2010 in Nagoya’s Aichi 
Prefecture, Japan, adopted a revised and updated strategic 
plan for biodiversity which is known as Aichi Biodiversity 
Targets. Under Goal B, Target 6 says “By 2020, all fish, 
invertebrate stocks and plants are managed and harvested 
sustainably”.
Some of the successful terrestrial bioprospecting contracts 
are worth looking at because they are the success indicators 
of the concept of access and benefit sharing arising out of 
natural resources and its rapid evolution.
Since territorial jurisdictions of marine ecosystems are 
complex they are regulated with several instruments shown 
below.
Various legal instruments and organizations related 
to coastal and marine genetic resources regulation is 
summarized below.
Marine bioprospecting contracts are different from other 
biopsopecting contracts because of the involvement of 
marine traditional knowledge, skilled sample collection 
and processing. Issues of ownerships beyond national 
jurisdictions are controversial. 
Marine bioprospecting is mainly for drug discovery and 
development which is a very long process. Ownership, 
monitoring and regulation are areas where clear processes 
have not been defined. Staggered payments in benefit sharing 
have been suggested because of the prolonged time involved 
in drug discovery. 
At present the Biological Diversity Act, 2002 enacted in line 
with the Convention of Biological Diversity says that foreign 
entities before undertaking any bioprospecting activity or 
transferring results of research related to the biodiversity 
should file applications for registration or grant of intellectual 
property rights and also need to seek permission from the 
Authority.
Equitable benefit sharing is also decided by the Authority 
under Section 21 of the Act. The Act has empowered the State 
Biodiversity Boards under Section 7 of the Act to approve 
collection of biological resources. However, there are no 
specific or distinct provisions in the Biological Diversity Act, 
2002 for regulation of marine bioprospecting. Indian contract 
Act 1872 is also prevailing, under Sections 10 and 11 say that 
any agreement to be a valid contract need to have clauses on 
consideration that can be either monetary or non-monetary 
or both.
A specific example of marine bioprospecting contract is the Fiji 
contract between the University of South Pacific in Fiji Islands 
and SmithKline Beecham and later with an Institute, Glasgow 
Strathclyde Institute of Drug Research. The agreement offered 
advantages of conservation of biodiversity, upliftment of 
the community and rights to the community to intervene 
such as the community was given the right to reclaim the 
sample after one year. As there were no provisions to protect 
traditional knowledge the agreement failed to meet the first 
condition of the CBD which is prior consent of the community 
for commercialization of outcomes.
Biomimicry
Drawing ideas from Mother Nature to create technologies 
and products mimicking nature is known as biomimicry. The 
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term was coined by Janine Benyus in 1997.  Her consulting 
firm Biomimicry 3.8 works with Nike, General Electric (GE) 
and Boeing to make smarter products and services. Constant 
researches by multidisciplinary teams have resulted in several 
new products and technologies out of which a few are 
described.
UV-reflective material is incorporated in Ornilux glass used in 
bird safe windows. In high rise building birds get killed by 
flying into windows with ordinary glass because they cannot 
see them. Biomicicry solved the problem when they found 
that spider webs contain UV reflective material which can be 
seen by birds and not by humans and bugs. Blue prints of cat 
paws are used in Continental Tyres enabling them to stop fast.
Biomimicry today has reached a stage where it can provide 
ecosystem services and set ecological performance standards 
because results of 3.8 billion years of research by nature 
are used or applied in biomimicry. For e.g., Carbon dioxide 
dissolved in seawater is used by corals which can be mimicked 
in the production of cement.
One of the latest examples is the development of a synthetic 
tree by researchers at Cornell University where water 
distribution is designed using capillary action without pumps 
and energy.
Sharkskin swimsuits used by swimmers in 2008 Olympics 
was made of a design mimicking the sharskins which are 
made of scales called dermal denticles which have grooves 
running down their length in alignment with water flow. 
These grooves disrupt formation of eddies or turbulent swirls 
of water making water pass by faster; prevent growth of other 
organisms including bacteria. Even though swimsuits made of 
such material were banned in sports, such surfaces are used is 
ship hulls and hospitals. 
Termite den design was used by an architect called Mick 
Pearce to design the Eastgate Centre in Harare, Zimbabwe 
studying the cooling chimneys and tunnels of termite dens. 
Supplemental air conditioning was reduced by 90% to heat 
and cool such a building.
Lotusan is the brand name of a paint developed mimicking 
the properties of lotus leaf’s property to repel water and dust 
with 4 years of research by a German Company called Ipso. 
The micro rough surface the paint creates similar to the lotus 
leaf surface is hydrophobic. The same principle is applied 
to develop glass containers from which food products like 
ketchups and sauces can be poured out completely by General 
Electric.
Velcro fasteners and straps are other widely known example 
of biomimicry. It was invented by a Swiss Engineer George 
de Mestral in 1941 after he removed some plant material 
adhering to his dog fur.
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